BD PurPrep, 8.3% recall — Carefusion 213, LLC (Class II)

Carefusion 213, LLC is recorded by the U.S. Food and Drug Administration (FDA) as recalling BD PurPrep, 8.3% — a Class II recall, initiated 2026-04-22 and posted to the FDA enforcement report on 2026-05-13, under recall number D-0518-2026. Status Ongoing, with no termination date on the record. The reason the FDA record carries is, verbatim: “Lack of assurance of Sterility: potential product contamination”. From the product description, the form is solution and the strengths given are 8.3%, 0.83%, 72.5% and 10.5 mL. 1 National Drug Code number is printed in the record: 54365-014-41. Distribution is recorded as “Nationwide in the USA” — Nationwide (US), with the recalling firm on record in TX, United States. The FDA files it under event ID 98790 together with 1 other recall number, all listed and linked below. Within that event this is the strength 8.3% · 0.83% · 72.5% · 10.5 mL and ndc 54365-014-41 configuration; the sibling records differ on strength and ndc and match on everything else the source states. Values are reproduced from the linked openFDA report; regulatory information, not medical advice.

Regulatory snapshot

Recall number D-0518-2026
FDA event ID 98790 (2 recall numbers)
Classification Class II (intermediate regulatory tier)
Status Ongoing
Recalling firm Carefusion 213, LLC
Recall initiated 2026-04-22
Reported by FDA 2026-05-13
Report lag 21 days from initiation to report
Distribution Nationwide in the USA — Nationwide (US)
Firm location on record TX, United States
Product description (source) BD PurPrep, Povidone-iodine 8.3% w/w (0.83% available iodine) with isopropyl alcohol 72.5% w/w Sterile Solution, 0.36 fl. oz. (10.5 mL) x 25 applicators per box. Carefusion 213, LLC, El Paso, TX 79912, subsidary of Becton Dickinson and Co. NDC 54365-014-41

Reason reported by FDA

Lack of assurance of Sterility: potential product contamination

8 words from the enforcement report field reason_for_recall, reproduced without edit — the firm's own wording, not an assessment.

Product identifiers in this record

6 identifying values matched by exact pattern in the 40-word product description above; each is a literal substring of it.

Product named BD PurPrep
Form Solution
Strength 8.3% · 0.83% · 72.5% · 10.5 mL
NDC 54365-014-41

Which configuration this record is

2 recall numbers share event 98790. They differ on strength and ndc and agree on everything else the source states, so those are the values to check a package against.

Attribute This record (D-0518-2026) D-0517-2026
Strength 8.3% · 0.83% · 72.5% · 10.5 mL 8.3% · 0.83% · 72.5% · 213 L
NDC 54365-014-41 54365-014-42

Shared across all 2 records under this event: form Solution; product named BD PurPrep; fda tier Class II; recalling firm Carefusion 213, LLC; the same reason text; initiated 2026-04-22; reported 2026-05-13.

Event context: 2 recall numbers under event 98790

One enforcement action, 2 recall numbers: the FDA filed 1 further configuration of this action under event 98790. Each keeps its own recall number and dates.

Recall recordRecall numberFDA tierStrength / formNDCReported
BD PurPrep, 8.3%D-0517-2026Class II8.3% · Solution54365-014-422026-05-13

Other indexed recalls from Carefusion 213, LLC

17 indexed records name Carefusion 213, LLC as the recalling firm, across 4 FDA events, reported 2026-05-13 to 2026-07-22. A coverage-limited activity count over the ingested window, not a quality rating.

Recall recordRecall numberFDA tierStrength / formReported
BD ChloraPrep Clear, 2%D-0690-2026Class II2% · Solution2026-07-22
BD ChloraPrep Hi-Lite Orange, 2%D-0643-2026Class II2% · Solution2026-07-08
BD PurPrep, 8.3%D-0644-2026Class II8.3% · Solution2026-07-08
BD ChloraPrep Clear, 2%D-0645-2026Class II2% · Solution2026-07-08
ChloraPrep FREPP, 2%D-0646-2026Class II2% · Solution2026-07-08
BD ChloraPrep Hi-Lite Orange, 2%D-0647-2026Class II2% · Solution2026-07-08
BD ChloraPrep Hi-Lite Orange, 2%D-0648-2026Class II2% · Solution2026-07-08
BD ChloraPrep Scrub Teal, 2%D-0649-2026Class II2% · Solution2026-07-08
BD ChloraPrep Scrub Teal, 2%D-0650-2026Class II2% · Solution2026-07-08
BD ChloraPrep CLear, 2%D-0651-2026Class II2% · Solution2026-07-08
BD ChloraPrep CLear, 2%D-0652-2026Class II2% · Solution2026-07-08
BD ChloraPrep Clear, 2%D-0622-2026Class II2% · Solution2026-07-01

Reported in the same month (2026-05)

48 enforcement reports carry a report date in 2026-05; these 8 are the Class II ones nearest this record.

Recall recordRecall numberRecalling firmFDA tierReported
DELFLEX, 1.5%D-0512-2026Fresenius Medical Care Holdings, Inc.Class II2026-05-13
DELFLEX, 2.5%D-0513-2026Fresenius Medical Care Holdings, Inc.Class II2026-05-13
Duloxetine Delayed-Release Capsules, 30 mgD-0514-2026Ajanta Pharma Ltd.Class II2026-05-13
Duloxetine Delayed-Release Capsules, 60 mgD-0515-2026Ajanta Pharma Ltd.Class II2026-05-13
Duloxetine Delayed-Release Capsules, 20 mgD-0516-2026Ajanta Pharma Ltd.Class II2026-05-13
Octreotide Acetate for Injectable Suspension, 30 mgD-0519-2026Teva Pharmaceuticals Usa, IncClass II2026-05-13
Enalapril Maleate Tablets, 20 mgD-0520-2026JB Chemicals And Pharmaceuticals LtdClass II2026-05-13
Duloxetine Delayed-Release Capsules USP, 60mgD-0522-2026Breckenridge Pharmaceutical, Inc.Class II2026-05-13

Reading this record

Class II is the FDA's own severity tier for the recall action — 213 of the 250 indexed records carry it — and it describes the agency's assessment of the action, not a risk statement about any individual. A search on event 98790 returns all 2 of these recall numbers; a search on D-0518-2026 returns only this configuration. Match a package against 54365-014-41 at the FDA source to confirm it is covered.

Namespace context: the Class II index (213 records) and the recall hub (250 records, 118 FDA events); Carefusion 213, LLC (17 indexed records) aggregates this firm across datasets.

Coverage and limits of this record

This page reflects the openFDA enforcement report for D-0518-2026 as ingested on 2026-08-22, which can lag the live FDA record and omits detail held only in primary documents. It offers no clinical assessment, no advice about whether to use any product, and no substitute. For any health question consult a qualified healthcare professional.

Source & provenance

Official source
https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0518-2026%22
Source dataset
openFDA Drug Enforcement API
Publication date
2026-05-13
Ingested
2026-08-22
Record hash
def4855483220bbf

Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.